AllQuantitative Report
logoArgusMay 05, 2021

RGEN: Lowering target price to $207.00

Symbols
RGEN
Sector(s)
Healthcare
Rating
Current Price
$191.52
Price Target
$NaN
Earnings Estimate
Summary

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free